ÀÇÎѵ¼º½

Cancer biomarkers are like a DNA fingerprint of a tumor, Dr. Vamsidhar Velcheti says.

At the Head and Neck Center, evaluation and treatment are vertically and horizontally integrated in one stop.

Research shows that COVID-19 vaccines pass antibodies from mother to child.

A pioneering ophthalmologist takes aim at Fuchs dystrophy progression in a new clinical trial.

New drugs to treat bladder, endometrial, and non-small cell lung cancer and melanoma were approved.

Dr. Faith E. Davies discusses the approval of second CAR T-cell therapy for multiple myeloma.

People receive world-class care at Long Island’s only full-service NCI-designated Comprehensive Cancer Center.

Dr. Nancy Chan selects clinical trials that best serve the diverse patient population.

Dr. Faith E. Davies will oversee development of a biospecimens resource for research on blood cancers.

The therapy is a potential game changer for treating this common form of bladder cancer.